According to the Zhitong Finance App, China Antibody-B (03681.HK) issued an announcement regarding the subsidiary's intention to sell Suzhou properties and facilities for 280 million yuan. The Board is pleased to announce that all the prerequisites contained in the sale agreement have been fulfilled and that the sale was completed on November 4, 2026 in accordance with the terms and conditions of the sale agreement. After completion, the target assets are no longer owned by the seller, and the company no longer has any interest in the target assets.

According to the Zhitong Finance App, China Antibody-B (03681.HK) issued an announcement regarding the subsidiary's intention to sell Suzhou properties and facilities for 280 million yuan. The Board is pleased to announce that all the prerequisites contained in the sale agreement have been fulfilled and that the sale was completed on November 4, 2026 in accordance with the terms and conditions of the sale agreement. After completion, the target assets are no longer owned by the seller, and the company no longer has any interest in the target assets.